Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 31, 2007
Grant Date -
May 19, 2005
app pub date -
Jun 25, 2004
filing date -
Jul 2, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to compounds of the Formulae (I)-(IV), wherein R.sub.1-R.sub.6, R.sub.11-R.sub.13, X and Y are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer ##STR00001##
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully